Baillie Gifford — DNLI Trade History
Quarter-by-quarter changes in the Denali Therapeutics position · CUSIP 24823R105
Currently held · 8.8 YearsFirst seen: 2017 Q4
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-06 | Reduce | 11,960,230 | -106,249 | -0.9% | $307.6M | 0.28% |
| 2026 Q1 | 2026-05-08 | Reduce | 12,066,479 | -244,410 | -2.0% | $231.7M | 0.24% |
| 2025 Q4 | 2026-01-23 | Add | 12,310,889 | 719,304 | +6.2% | $203.3M | 0.17% |
| 2025 Q3 | 2025-10-31 | Reduce | 11,591,585 | -363,738 | -3.0% | $168.3M | 0.13% |
| 2025 Q2 | 2025-08-06 | Reduce | 11,955,323 | -134,717 | -1.1% | $167.3M | 0.13% |
| 2025 Q1 | 2025-05-07 | Reduce | 12,090,040 | -223,891 | -1.8% | $164.4M | 0.14% |
| 2024 Q4 | 2025-01-31 | Reduce | 12,313,931 | -1,031,956 | -7.7% | $251.0M | 0.19% |
| 2024 Q3 | 2024-11-05 | Reduce | 13,345,887 | -417,709 | -3.0% | $388.8M | 0.29% |
| 2024 Q2 | 2024-07-25 | Reduce | 13,763,596 | -277,632 | -2.0% | $319.6M | 0.25% |
| 2024 Q1 | 2024-05-01 | Reduce | 14,041,228 | -219,496 | -1.5% | $288.1M | 0.22% |
| 2023 Q4 | 2024-01-26 | Reduce | 14,260,724 | -420,303 | -2.9% | $306.0M | 0.24% |
| 2023 Q3 | 2023-11-13 | Reduce | 14,681,027 | -162,743 | -1.1% | $302.9M | 0.28% |
| 2023 Q2 | 2023-07-28 | Reduce | 14,843,770 | -508,341 | -3.3% | $438.0M | 0.37% |
| 2023 Q1 | 2023-05-03 | Add | 15,352,111 | 232,637 | +1.5% | $353.7M | 0.32% |
| 2022 Q4 | 2023-03-10 | Add | 15,119,474 | 404,423 | +2.7% | $420.5M | 0.44% |
| 2022 Q3 | 2022-10-27 | Reduce | 14,715,051 | -154,323 | -1.0% | $451.6M | 0.47% |
| 2022 Q2 | 2022-08-08 | Reduce | 14,869,374 | -111,058 | -0.7% | $437.6M | 0.45% |
| 2022 Q1 | 2022-05-05 | Reduce | 14,980,432 | -75,949 | -0.5% | $481.9M | 0.34% |
| 2021 Q4 | 2022-01-20 | Add | 15,056,381 | 46,565 | +0.3% | $671.5M | 0.37% |
| 2021 Q3 | 2021-10-19 | Reduce | 15,009,816 | -137,797 | -0.9% | $757.2M | 0.40% |
| 2021 Q2 | 2021-08-02 | Add | 15,147,613 | 2,152,416 | +16.6% | $1.19B | 0.58% |
| 2021 Q1 | 2021-05-06 | Add | 12,995,197 | 804,941 | +6.6% | $742.0M | 0.41% |
| 2020 Q4 | 2021-02-10 | Add | 12,190,256 | 1,363,078 | +12.6% | $1.02B | 0.57% |
| 2020 Q3 | 2020-11-12 | Add | 10,827,178 | 1,547,984 | +16.7% | $387.9M | 0.27% |
| 2020 Q2 | 2020-08-12 | Add | 9,279,194 | 149,442 | +1.6% | $224.4M | 0.17% |
| 2020 Q1 | 2020-05-08 | Add | 9,129,752 | 1,539,505 | +20.3% | $159.9M | 0.17% |
| 2019 Q4 | 2020-02-10 | Add | 7,590,247 | 226,784 | +3.1% | $132.2M | 0.13% |
| 2019 Q3 | 2019-11-07 | Reduce | 7,363,463 | -43,766 | -0.6% | $112.8M | 0.13% |
| 2019 Q2 | 2019-08-08 | Add | 7,407,229 | 1,145,003 | +18.3% | $153.8M | 0.16% |
| 2019 Q1 | 2019-05-01 | Add | 6,262,226 | 34,502 | +0.6% | $145.4M | 0.16% |
| 2018 Q4 | 2019-02-14 | Add | 6,227,724 | 741,303 | +13.5% | $128.7M | 0.17% |
| 2018 Q3 | 2018-11-13 | Add | 5,486,421 | 141,788 | +2.7% | $119.3M | 0.13% |
| 2018 Q2 | 2018-07-17 | Add | 5,344,633 | 151,787 | +2.9% | $81.5M | 0.09% |
| 2018 Q1 | 2018-05-10 | Add | 5,192,846 | 271,063 | +5.5% | $102.2M | 0.12% |
| 2017 Q4 | 2018-02-13 | New | 4,921,783 | 4,921,783 | — | $77.0M | 0.10% |
| 2017 Q3 | 2017-10-20 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-10 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-12 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-14 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-09 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.